![](https://img.group-telegram.com/icon/Pi/PillNews.jpg)
药丸时报 Telegram | DID YOU KNOW?
Date: | 药丸时报
What distinguishes the app from competitors is its use of what's known as channels: Public or private feeds of photos and videos that can be set up by one person or an organization. The channels have become popular with on-the-ground journalists, aid workers and Ukrainian President Volodymyr Zelenskyy, who broadcasts on a Telegram channel. The channels can be followed by an unlimited number of people. Unlike Facebook, Twitter and other popular social networks, there is no advertising on Telegram and the flow of information is not driven by an algorithm. The regulator said it had received information that messages containing stock tips and other investment advice with respect to selected listed companies are being widely circulated through websites and social media platforms such as Telegram, Facebook, WhatsApp and Instagram. In February 2014, the Ukrainian people ousted pro-Russian president Viktor Yanukovych, prompting Russia to invade and annex the Crimean peninsula. By the start of April, Pavel Durov had given his notice, with TechCrunch saying at the time that the CEO had resisted pressure to suppress pages criticizing the Russian government. Groups are also not fully encrypted, end-to-end. This includes private groups. Private groups cannot be seen by other Telegram users, but Telegram itself can see the groups and all of the communications that you have in them. All of the same risks and warnings about channels can be applied to groups. In a message on his Telegram channel recently recounting the episode, Durov wrote: "I lost my company and my home, but would do it again – without hesitation."
药丸时报 from sa
药丸时报
group-telegram.com/PillNews
China cn telegram Group & telegram Channel 10
![](https://img.group-telegram.com/icon/Pi/PillNews.jpg)
Created:
From: China and China
Telegram 药丸时报, 59042 Telegram Group & Telegram Channel China, cnTelegram 药丸时报, 59042 Telegram Group & Telegram Channel, China, CN
https://t.me/PillNews
Webview